These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 12921494)

  • 21. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.
    Loder E; Freitag FG; Adelman J; Pearlmand S; Abu-Shakra S
    Curr Med Res Opin; 2005 Mar; 21(3):381-9. PubMed ID: 15811207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
    Rothner AD; Wasiewski W; Winner P; Lewis D; Stankowski J
    Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache.
    Mauskop A; Farkkila M; Hering-Hanit R; Rapoport A; Warner J
    Curr Med Res Opin; 1999; 15(4):282-9. PubMed ID: 10640260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan.
    Edmeads JG; Millson DS
    Cephalalgia; 1997 Oct; 17 Suppl 18():41-52. PubMed ID: 9399016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study.
    Cittadini E; May A; Straube A; Evers S; Bussone G; Goadsby PJ
    Arch Neurol; 2006 Nov; 63(11):1537-42. PubMed ID: 16966497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A long-term study to maximise migraine relief with zolmitriptan.
    Tepper SJ; Donnan GA; Dowson AJ; Bomhof MA; Elkind A; Meloche J; Fletcher PE; Millson DS
    Curr Med Res Opin; 1999; 15(4):254-71. PubMed ID: 10640258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics, dose proportionality, and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers.
    Yates R; Nairn K; Dixon R; Kemp JV; Dane AL
    J Clin Pharmacol; 2002 Nov; 42(11):1244-50. PubMed ID: 12412823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zolmitriptan provides consistent migraine relief when used in the long-term.
    Tuchman M; Edvinsson L; Geraud G; Korczyn A; Mauskop A; Pfaffenrath V
    Curr Med Res Opin; 1999; 15(4):272-81. PubMed ID: 10640259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zolmitriptan Nasal Spray: A Review in Acute Migraine in Pediatric Patients 12 Years of Age or Older.
    McKeage K
    Paediatr Drugs; 2016 Feb; 18(1):75-81. PubMed ID: 26747634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
    Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies.
    Hedlund C; Rapoport AM; Dodick DW; Goadsby PJ
    Headache; 2009 Oct; 49(9):1315-23. PubMed ID: 19788472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study.
    Rapoport AM; Mathew NT; Silberstein SD; Dodick D; Tepper SJ; Sheftell FD; Bigal ME
    Neurology; 2007 Aug; 69(9):821-6. PubMed ID: 17724283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of zolmitriptan and its clinical applications in migraine.
    Dowson AJ; Charlesworth B
    Expert Opin Pharmacother; 2002 Jul; 3(7):993-1005. PubMed ID: 12083998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 311C90: long-term efficacy and tolerability profile for the acute treatment of migraine. International 311C90 Long-Term Study Group.
    Zagami AS
    Neurology; 1997 Mar; 48(3 Suppl 3):S25-8. PubMed ID: 9071267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study].
    Stöckli HR; Sword A
    Praxis (Bern 1994); 2003 Feb; 92(9):379-89. PubMed ID: 12674591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose-response study.
    Sakai F; Iwata M; Tashiro K; Itoyama Y; Tsuji S; Fukuuchi Y; Sobue G; Nakashima K; Morimatsu M
    Cephalalgia; 2002 Jun; 22(5):376-83. PubMed ID: 12110113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spotlight on almotriptan in migraine.
    Keam SJ; Goa KL; Figgitt DP
    CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
    Spierings EL; Brandes JL; Kudrow DB; Weintraub J; Schmidt PC; Kellerman DJ; Tepper SJ
    Cephalalgia; 2018 Feb; 38(2):215-224. PubMed ID: 29022755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine.
    Dowson AJ; MacGregor EA; Purdy RA; Becker WJ; Green J; Levy SL
    Cephalalgia; 2002 Mar; 22(2):101-6. PubMed ID: 11972576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Almotriptan: a review of its use in migraine.
    Keam SJ; Goa KL; Figgitt DP
    Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.